Metformin use amid coronavirus disease 2019 pandemic
Abstract
There are a few aspects that we would like to add to complement the discussion in EL-Arabey and Abdalla [1]. Firstly, the authors suggested that the reduction of weight with the use of metformin, especially among obese patients, may have a protective effect on mortality from COVID-19. This article is protected by copyright. All rights reserved.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.